CLINICAL_TRIALS trial_result · 2026-01-27

Clinical Trial Update: A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours [Phase 1]

Phase 1 trial evaluating a safe dose of BI 754091 in patients with solid tumors has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2026-01-27